AngioDynamics ANGO Business Segments
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| Gross Profit by Business | ||||||
| Med Device | $80.72M+3.7% | $81.8M+4.2% | $80.1M-3.7% | $79.19M-9.5% | $77.81M-19.8% | |
| Med Tech | $89.62M+17.6% | $85.91M+18.6% | $82.74M+21.4% | $78.52M+16.8% | $76.2M+16.2% | |
| Cost of sales (exclusive of intangible amortization) by Business | ||||||
| Med Device | $89.02M-2.1% | $87.46M-9.8% | $86.67M-15.9% | $86.65M-21.2% | $90.89M-20.9% | |
| Med Tech | $54.37M+25.7% | $52.13M+26.2% | $51.21M+29.1% | $48.14M+22.8% | $43.27M+13.6% | |
| Net Sales by Product | ||||||
| Med Device | $169.74M+4.1% | $169.26M-1.5% | $166.77M-9.5% | $165.84M-16.0% | $163.12M-26.0% | |
| Med Tech | $143.99M+19.8% | $138.05M+20.4% | $133.95M+23.4% | $126.65M+19.0% | $120.2M+16.1% | |
| Net Sales by Geography | ||||||
| International | $44.91M+14.9% | $44.43M+7.7% | $42.76M-7.4% | $41.52M-20.8% | $39.08M-33.6% | |
| United States | $268.81M+10.1% | $262.87M+7.2% | $257.96M+4.6% | $250.98M-0.2% | $244.24M-7.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does AngioDynamics break its business down?
- AngioDynamics (ANGO) reports gross profit by business across 2 parts — Med Device and Med Tech. Each is extracted from the segment footnotes and tracked over time.
- Where does AngioDynamics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in AngioDynamics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
